Inhibition of hippocampal acetylcholine release by cannabinoids: reversal by SR 141716A

Author： Gessa G.L. Mascia M.S. Casu M.A. Carta G.

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.327, Iss.1, 1997-05, pp. : 1-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cannabinoids decrease acetylcholine release in the medial-prefrontal cortex and hippocampus, reversal by SR 141716A

By Gessa G.L. Casu M.A. Carta G. Mascia M.S.

European Journal of Pharmacology, Vol. 355, Iss. 2, 1998-08 ,pp. : 119-124

Elsevier

Access to resources Recommend Favorite

Rimonabant: SR 141716, SR 141716a

Drugs in R&D, Vol. 3, Iss. 1, 2002-01 ,pp. : 65-66

Adis International

Access to resources Recommend Favorite

GABA receptors and benzodiazepine binding sites modulate hippocampal acetylcholine release in vivo

By Moor E. DeBoer P. Westerink B.H.C.

European Journal of Pharmacology, Vol. 359, Iss. 2, 1998-10 ,pp. : 119-126

Elsevier

Access to resources Recommend Favorite

Increased hippocampal acetylcholine release during a working memory task

By Fadda F. Melis F. Stancampiano R.

European Journal of Pharmacology, Vol. 307, Iss. 2, 1996-06 ,pp. : 1-2

Elsevier

Access to resources Recommend Favorite

9 -tetrahydrocannabinol enhances cortical and hippocampal acetylcholine release in vivo: a microdialysis study

By Acquas E. Pisanu A. Marrocu P. Goldberg S.R. Di Chiara G.

European Journal of Pharmacology, Vol. 419, Iss. 2, 2001-05 ,pp. : 155-161

Elsevier

Access to resources Recommend Favorite